Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Angioplasty, Balloon, Coronary | 39 | 2013 | 1866 | 1.630 |
Why?
|
Drug-Eluting Stents | 19 | 2015 | 755 | 0.910 |
Why?
|
Osteoarthritis, Knee | 10 | 2023 | 1215 | 0.830 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 14 | 2016 | 311 | 0.740 |
Why?
|
Stents | 20 | 2015 | 3282 | 0.570 |
Why?
|
Registries | 38 | 2016 | 8173 | 0.500 |
Why?
|
Arthroplasty, Replacement, Knee | 7 | 2023 | 1351 | 0.490 |
Why?
|
Obesity, Morbid | 6 | 2023 | 1255 | 0.430 |
Why?
|
Coronary Artery Disease | 20 | 2016 | 6456 | 0.420 |
Why?
|
Bariatric Surgery | 6 | 2021 | 981 | 0.390 |
Why?
|
Coronary Disease | 14 | 2012 | 5928 | 0.380 |
Why?
|
Gastric Bypass | 4 | 2023 | 828 | 0.360 |
Why?
|
Pain Measurement | 5 | 2024 | 3442 | 0.310 |
Why?
|
Exercise Therapy | 3 | 2019 | 903 | 0.290 |
Why?
|
Myocardial Infarction | 25 | 2016 | 11661 | 0.290 |
Why?
|
Myocardial Revascularization | 6 | 2012 | 835 | 0.280 |
Why?
|
Menopause | 7 | 2016 | 1615 | 0.260 |
Why?
|
Lupus Erythematosus, Systemic | 5 | 2009 | 2102 | 0.260 |
Why?
|
Carotid Artery Diseases | 3 | 2014 | 862 | 0.250 |
Why?
|
Catastrophization | 2 | 2020 | 332 | 0.240 |
Why?
|
Coronary Vessels | 5 | 2014 | 3073 | 0.230 |
Why?
|
Spondylarthritis | 1 | 2024 | 60 | 0.210 |
Why?
|
Spondylitis, Ankylosing | 1 | 2024 | 154 | 0.210 |
Why?
|
Diabetes Complications | 6 | 2021 | 1319 | 0.200 |
Why?
|
Women's Health | 4 | 2016 | 2037 | 0.200 |
Why?
|
Vasomotor System | 2 | 2012 | 211 | 0.190 |
Why?
|
Hot Flashes | 3 | 2012 | 320 | 0.190 |
Why?
|
Coronary Restenosis | 7 | 2013 | 426 | 0.180 |
Why?
|
Uveitis | 1 | 2024 | 379 | 0.180 |
Why?
|
Preoperative Period | 3 | 2020 | 551 | 0.180 |
Why?
|
Home Care Services, Hospital-Based | 1 | 2019 | 43 | 0.170 |
Why?
|
Metals | 6 | 2015 | 708 | 0.170 |
Why?
|
Treatment Outcome | 41 | 2024 | 63767 | 0.170 |
Why?
|
Middle Aged | 72 | 2021 | 214698 | 0.170 |
Why?
|
Diabetes Mellitus | 8 | 2021 | 5773 | 0.170 |
Why?
|
Frail Elderly | 1 | 2024 | 720 | 0.170 |
Why?
|
Knee Injuries | 1 | 2023 | 484 | 0.160 |
Why?
|
Laparoscopy | 3 | 2022 | 2149 | 0.160 |
Why?
|
Coronary Stenosis | 3 | 2011 | 814 | 0.160 |
Why?
|
Clubfoot | 1 | 2019 | 61 | 0.160 |
Why?
|
Aortic Diseases | 1 | 2004 | 702 | 0.150 |
Why?
|
Musculoskeletal Diseases | 1 | 2024 | 590 | 0.150 |
Why?
|
Coronary Angiography | 13 | 2014 | 4512 | 0.150 |
Why?
|
Aged | 58 | 2024 | 164457 | 0.150 |
Why?
|
Female | 86 | 2024 | 382565 | 0.140 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1369 | 0.140 |
Why?
|
United States | 39 | 2021 | 70474 | 0.130 |
Why?
|
Weight Loss | 4 | 2023 | 2670 | 0.130 |
Why?
|
Hip Fractures | 1 | 2024 | 967 | 0.130 |
Why?
|
Risk Factors | 33 | 2024 | 72453 | 0.130 |
Why?
|
Follicle Stimulating Hormone | 2 | 2015 | 726 | 0.130 |
Why?
|
Male | 74 | 2024 | 351538 | 0.130 |
Why?
|
Disability Evaluation | 2 | 2024 | 1810 | 0.130 |
Why?
|
Renal Insufficiency | 2 | 2016 | 787 | 0.130 |
Why?
|
Carotid Arteries | 2 | 2014 | 933 | 0.120 |
Why?
|
Follow-Up Studies | 22 | 2021 | 38800 | 0.120 |
Why?
|
Gastroplasty | 2 | 2016 | 152 | 0.120 |
Why?
|
Humans | 97 | 2024 | 746839 | 0.120 |
Why?
|
Pain, Postoperative | 2 | 2024 | 1659 | 0.120 |
Why?
|
Orthopedic Procedures | 1 | 2024 | 1251 | 0.120 |
Why?
|
Angina, Unstable | 2 | 2009 | 917 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2021 | 1047 | 0.110 |
Why?
|
Prescriptions | 1 | 2016 | 382 | 0.110 |
Why?
|
Hospital Mortality | 13 | 2012 | 5218 | 0.110 |
Why?
|
Aorta | 1 | 2001 | 2026 | 0.110 |
Why?
|
Cardiovascular Agents | 3 | 2016 | 847 | 0.110 |
Why?
|
Compression Bandages | 1 | 2012 | 14 | 0.110 |
Why?
|
Hemorrhage | 2 | 2016 | 3521 | 0.110 |
Why?
|
Prosthesis Design | 7 | 2014 | 2109 | 0.100 |
Why?
|
Coronary Circulation | 2 | 2010 | 1558 | 0.100 |
Why?
|
Proportional Hazards Models | 13 | 2013 | 12280 | 0.100 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1569 | 0.100 |
Why?
|
Prospective Studies | 21 | 2020 | 53268 | 0.100 |
Why?
|
Retreatment | 5 | 2011 | 600 | 0.100 |
Why?
|
Arthralgia | 1 | 2015 | 452 | 0.100 |
Why?
|
Coronary Aneurysm | 1 | 2013 | 231 | 0.090 |
Why?
|
Vascular Diseases | 2 | 2013 | 1161 | 0.090 |
Why?
|
Blood Flow Velocity | 3 | 2005 | 1367 | 0.090 |
Why?
|
Binge-Eating Disorder | 1 | 2012 | 150 | 0.090 |
Why?
|
Time Factors | 19 | 2016 | 39639 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 3017 | 0.090 |
Why?
|
Academies and Institutes | 1 | 2012 | 312 | 0.090 |
Why?
|
Coronary Artery Bypass | 9 | 2011 | 2250 | 0.090 |
Why?
|
Drug Utilization | 1 | 2016 | 1173 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2014 | 789 | 0.090 |
Why?
|
Age Factors | 11 | 2024 | 18159 | 0.090 |
Why?
|
Chi-Square Distribution | 6 | 2012 | 3430 | 0.090 |
Why?
|
Patient Compliance | 2 | 2018 | 2676 | 0.080 |
Why?
|
Telemetry | 1 | 2010 | 198 | 0.080 |
Why?
|
beta 2-Glycoprotein I | 1 | 2009 | 28 | 0.080 |
Why?
|
Comorbidity | 9 | 2018 | 10376 | 0.080 |
Why?
|
Pain | 3 | 2023 | 4983 | 0.080 |
Why?
|
Hemostasis | 1 | 2011 | 447 | 0.080 |
Why?
|
Prescription Drugs | 1 | 2016 | 615 | 0.080 |
Why?
|
Patient Discharge | 2 | 2016 | 3316 | 0.080 |
Why?
|
Diabetic Angiopathies | 2 | 2011 | 811 | 0.080 |
Why?
|
Motor Activity | 1 | 2018 | 2670 | 0.080 |
Why?
|
Obesity | 5 | 2023 | 12726 | 0.080 |
Why?
|
Gastrectomy | 2 | 2023 | 671 | 0.080 |
Why?
|
After-Hours Care | 1 | 2008 | 99 | 0.080 |
Why?
|
Sex Factors | 7 | 2011 | 10286 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3647 | 0.070 |
Why?
|
Peripheral Vascular Diseases | 1 | 2010 | 513 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 4 | 2016 | 3118 | 0.070 |
Why?
|
Severity of Illness Index | 9 | 2020 | 15561 | 0.070 |
Why?
|
Tunica Intima | 2 | 2013 | 446 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 2385 | 0.070 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2010 | 391 | 0.070 |
Why?
|
Survival Rate | 9 | 2013 | 12645 | 0.070 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1040 | 0.070 |
Why?
|
Lipoproteins | 1 | 2012 | 882 | 0.070 |
Why?
|
Sweating | 3 | 2012 | 154 | 0.070 |
Why?
|
Kidney Failure, Chronic | 2 | 2011 | 2452 | 0.070 |
Why?
|
Computer Systems | 1 | 2008 | 471 | 0.070 |
Why?
|
Arterial Occlusive Diseases | 1 | 2011 | 754 | 0.070 |
Why?
|
Iliac Aneurysm | 1 | 2006 | 36 | 0.070 |
Why?
|
Insulin | 3 | 2012 | 6479 | 0.070 |
Why?
|
Risk Assessment | 10 | 2016 | 23470 | 0.070 |
Why?
|
Blood Transfusion | 2 | 2016 | 1287 | 0.070 |
Why?
|
Blood Vessel Prosthesis Implantation | 2 | 2006 | 1387 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 6 | 2013 | 6462 | 0.070 |
Why?
|
Osteoporotic Fractures | 1 | 2010 | 397 | 0.060 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2011 | 530 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 347 | 0.060 |
Why?
|
Cause of Death | 3 | 2011 | 3618 | 0.060 |
Why?
|
Heart Failure | 4 | 2011 | 11100 | 0.060 |
Why?
|
Creatinine | 2 | 2007 | 1850 | 0.060 |
Why?
|
Telephone | 1 | 2008 | 619 | 0.060 |
Why?
|
Recurrence | 5 | 2019 | 8387 | 0.060 |
Why?
|
Patient Readmission | 2 | 2024 | 3180 | 0.060 |
Why?
|
Longitudinal Studies | 6 | 2021 | 14125 | 0.060 |
Why?
|
Thrombosis | 3 | 2013 | 2999 | 0.060 |
Why?
|
Collateral Circulation | 1 | 2005 | 276 | 0.060 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 2005 | 191 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2598 | 0.060 |
Why?
|
Patient Selection | 1 | 2016 | 4197 | 0.060 |
Why?
|
Triglycerides | 1 | 2012 | 2434 | 0.060 |
Why?
|
Aorta, Abdominal | 1 | 2007 | 600 | 0.060 |
Why?
|
Adult | 19 | 2021 | 215288 | 0.060 |
Why?
|
Fibrinogen | 2 | 2011 | 866 | 0.060 |
Why?
|
Retrospective Studies | 16 | 2024 | 78360 | 0.060 |
Why?
|
Embolism | 1 | 2007 | 405 | 0.060 |
Why?
|
Remission Induction | 2 | 2021 | 2369 | 0.050 |
Why?
|
Pulsatile Flow | 1 | 2004 | 316 | 0.050 |
Why?
|
Carotid Artery, Internal | 1 | 2005 | 430 | 0.050 |
Why?
|
Death, Sudden, Cardiac | 1 | 2011 | 1529 | 0.050 |
Why?
|
Stroke Volume | 4 | 2011 | 5142 | 0.050 |
Why?
|
Angina Pectoris | 1 | 2006 | 968 | 0.050 |
Why?
|
Quality of Life | 4 | 2019 | 12979 | 0.050 |
Why?
|
Hematoma | 1 | 2007 | 768 | 0.050 |
Why?
|
Calcinosis | 1 | 2011 | 1415 | 0.050 |
Why?
|
Cohort Studies | 9 | 2024 | 40538 | 0.050 |
Why?
|
Carotid Stenosis | 2 | 2009 | 850 | 0.050 |
Why?
|
Graft Occlusion, Vascular | 1 | 2005 | 546 | 0.050 |
Why?
|
Exercise | 1 | 2018 | 5689 | 0.050 |
Why?
|
Blood Glucose | 3 | 2012 | 6220 | 0.050 |
Why?
|
Mental Health | 1 | 2015 | 3087 | 0.050 |
Why?
|
Immunosuppressive Agents | 3 | 2012 | 4057 | 0.050 |
Why?
|
Minority Groups | 1 | 2008 | 1197 | 0.050 |
Why?
|
Myocardial Ischemia | 2 | 2009 | 2142 | 0.050 |
Why?
|
Linear Models | 3 | 2019 | 5833 | 0.050 |
Why?
|
Estradiol | 3 | 2012 | 1946 | 0.050 |
Why?
|
Aged, 80 and over | 10 | 2024 | 57622 | 0.050 |
Why?
|
Medical Errors | 1 | 2008 | 1250 | 0.040 |
Why?
|
Blood Vessel Prosthesis | 1 | 2005 | 920 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2860 | 0.040 |
Why?
|
Postoperative Period | 2 | 2020 | 1812 | 0.040 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2812 | 0.040 |
Why?
|
Inpatients | 2 | 2009 | 2517 | 0.040 |
Why?
|
Physical Therapy Modalities | 1 | 2023 | 530 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2024 | 444 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2012 | 2847 | 0.040 |
Why?
|
Back Pain | 1 | 2024 | 540 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5469 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2003 | 597 | 0.040 |
Why?
|
Postoperative Complications | 6 | 2013 | 15365 | 0.040 |
Why?
|
Incidence | 7 | 2013 | 20821 | 0.040 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1770 | 0.040 |
Why?
|
Heart Transplantation | 1 | 2013 | 3032 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3420 | 0.040 |
Why?
|
Odds Ratio | 5 | 2016 | 9600 | 0.040 |
Why?
|
Musculoskeletal Manipulations | 1 | 2018 | 24 | 0.040 |
Why?
|
Elasticity | 1 | 2001 | 653 | 0.040 |
Why?
|
Tenotomy | 1 | 2019 | 55 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 3030 | 0.040 |
Why?
|
Benchmarking | 1 | 2005 | 1029 | 0.040 |
Why?
|
Insulin Resistance | 1 | 2012 | 3841 | 0.040 |
Why?
|
Braces | 1 | 2019 | 137 | 0.040 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2011 | 1821 | 0.040 |
Why?
|
Serum Albumin | 1 | 2001 | 672 | 0.040 |
Why?
|
Multicenter Studies as Topic | 2 | 2018 | 1678 | 0.040 |
Why?
|
Casts, Surgical | 1 | 2019 | 179 | 0.040 |
Why?
|
Models, Cardiovascular | 1 | 2003 | 958 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5762 | 0.040 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2007 | 1192 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2535 | 0.040 |
Why?
|
Haiti | 1 | 2019 | 540 | 0.040 |
Why?
|
Kidney | 2 | 2016 | 6990 | 0.040 |
Why?
|
Anticoagulants | 1 | 2012 | 4731 | 0.040 |
Why?
|
Femoral Artery | 1 | 2001 | 833 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8492 | 0.030 |
Why?
|
Resistance Training | 1 | 2018 | 174 | 0.030 |
Why?
|
Coronary Thrombosis | 2 | 2011 | 485 | 0.030 |
Why?
|
Czech Republic | 1 | 2016 | 73 | 0.030 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 3148 | 0.030 |
Why?
|
Canada | 2 | 2016 | 2090 | 0.030 |
Why?
|
Angioplasty | 2 | 2010 | 361 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 465 | 0.030 |
Why?
|
Glomerular Filtration Rate | 2 | 2016 | 2145 | 0.030 |
Why?
|
Length of Stay | 4 | 2012 | 6299 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2016 | 2708 | 0.030 |
Why?
|
Poisson Distribution | 1 | 2016 | 506 | 0.030 |
Why?
|
Life Tables | 2 | 2006 | 368 | 0.030 |
Why?
|
Prognosis | 5 | 2018 | 29078 | 0.030 |
Why?
|
C-Reactive Protein | 2 | 2011 | 3752 | 0.030 |
Why?
|
Smoking | 3 | 2011 | 8983 | 0.030 |
Why?
|
Health Services Accessibility | 2 | 2009 | 5243 | 0.030 |
Why?
|
C-Peptide | 1 | 2016 | 424 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1219 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3273 | 0.030 |
Why?
|
Contrast Media | 1 | 2007 | 5255 | 0.030 |
Why?
|
Predictive Value of Tests | 5 | 2012 | 15012 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6319 | 0.030 |
Why?
|
Guideline Adherence | 2 | 2018 | 2189 | 0.030 |
Why?
|
Recovery of Function | 1 | 2024 | 2925 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2010 | 7788 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2012 | 10750 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2281 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2010 | 1510 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2011 | 12021 | 0.030 |
Why?
|
Clinical Competence | 1 | 2008 | 4678 | 0.030 |
Why?
|
Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2010 | 15386 | 0.030 |
Why?
|
Tunica Media | 1 | 2013 | 105 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2012 | 8521 | 0.030 |
Why?
|
Renal Dialysis | 2 | 2016 | 1695 | 0.030 |
Why?
|
Follicle Stimulating Hormone, Human | 1 | 2012 | 25 | 0.030 |
Why?
|
Radiation-Protective Agents | 1 | 1993 | 88 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10098 | 0.030 |
Why?
|
Age Distribution | 2 | 2011 | 2841 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2016 | 11965 | 0.030 |
Why?
|
Inflammation | 1 | 2011 | 10635 | 0.020 |
Why?
|
Body Mass Index | 3 | 2018 | 12658 | 0.020 |
Why?
|
Factor VII | 1 | 2011 | 133 | 0.020 |
Why?
|
Reward | 1 | 2018 | 935 | 0.020 |
Why?
|
Regression Analysis | 1 | 2001 | 6337 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2021 | 2689 | 0.020 |
Why?
|
Logistic Models | 3 | 2016 | 13172 | 0.020 |
Why?
|
Hospitalization | 5 | 2009 | 10342 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 2 | 2010 | 17448 | 0.020 |
Why?
|
Atherectomy, Coronary | 1 | 2011 | 145 | 0.020 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6463 | 0.020 |
Why?
|
Angiography | 2 | 2006 | 1597 | 0.020 |
Why?
|
Risk | 3 | 2011 | 9522 | 0.020 |
Why?
|
Hyperplasia | 1 | 2013 | 1154 | 0.020 |
Why?
|
Arthroscopy | 1 | 2016 | 948 | 0.020 |
Why?
|
Aspirin | 2 | 2012 | 3288 | 0.020 |
Why?
|
Insulin, Long-Acting | 1 | 2009 | 57 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 516 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1993 | 1251 | 0.020 |
Why?
|
Models, Statistical | 1 | 2003 | 5037 | 0.020 |
Why?
|
Research Design | 2 | 2019 | 6066 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2012 | 612 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2009 | 296 | 0.020 |
Why?
|
Patient Care Team | 1 | 2019 | 2480 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 633 | 0.020 |
Why?
|
Motivation | 1 | 2018 | 1966 | 0.020 |
Why?
|
Nitrates | 1 | 2009 | 260 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7281 | 0.020 |
Why?
|
Preoperative Care | 1 | 2016 | 2223 | 0.020 |
Why?
|
Saphenous Vein | 1 | 2010 | 523 | 0.020 |
Why?
|
Product Labeling | 1 | 2008 | 76 | 0.020 |
Why?
|
Ticlopidine | 1 | 2012 | 892 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 13814 | 0.020 |
Why?
|
Psychotropic Drugs | 1 | 2012 | 880 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2012 | 15314 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2016 | 1645 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2009 | 689 | 0.020 |
Why?
|
Observation | 1 | 2008 | 313 | 0.020 |
Why?
|
North America | 1 | 2009 | 1265 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2011 | 1152 | 0.020 |
Why?
|
Mood Disorders | 1 | 2012 | 1103 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2016 | 2563 | 0.020 |
Why?
|
Hospital Records | 1 | 2005 | 91 | 0.020 |
Why?
|
Sirolimus | 1 | 2012 | 1532 | 0.020 |
Why?
|
Lupus Nephritis | 1 | 2009 | 311 | 0.020 |
Why?
|
Paclitaxel | 1 | 2012 | 1693 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15311 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2009 | 612 | 0.020 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 494 | 0.020 |
Why?
|
Iliac Artery | 1 | 2006 | 342 | 0.020 |
Why?
|
Affect | 1 | 2012 | 1459 | 0.020 |
Why?
|
Coronary Occlusion | 1 | 2007 | 303 | 0.010 |
Why?
|
Polysomnography | 1 | 2011 | 1790 | 0.010 |
Why?
|
Survival Analysis | 2 | 2008 | 10139 | 0.010 |
Why?
|
Cost of Illness | 1 | 2013 | 1876 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9213 | 0.010 |
Why?
|
Hip Joint | 1 | 2010 | 997 | 0.010 |
Why?
|
Propensity Score | 1 | 2011 | 1848 | 0.010 |
Why?
|
Vascular Patency | 1 | 2006 | 889 | 0.010 |
Why?
|
Area Under Curve | 1 | 2007 | 1617 | 0.010 |
Why?
|
Primary Health Care | 2 | 2010 | 4592 | 0.010 |
Why?
|
Venous Thrombosis | 1 | 2012 | 1267 | 0.010 |
Why?
|
Reproducibility of Results | 3 | 2007 | 19825 | 0.010 |
Why?
|
Workload | 1 | 2008 | 841 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2722 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7686 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 2010 | 1876 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2012 | 5096 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3355 | 0.010 |
Why?
|
Collagen | 1 | 2010 | 2624 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3534 | 0.010 |
Why?
|
Hypoglycemia | 1 | 2009 | 844 | 0.010 |
Why?
|
Home Care Services | 1 | 2008 | 627 | 0.010 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2005 | 773 | 0.010 |
Why?
|
Shock, Cardiogenic | 1 | 2007 | 699 | 0.010 |
Why?
|
Fatigue | 1 | 2008 | 1520 | 0.010 |
Why?
|
Homeostasis | 1 | 2012 | 3268 | 0.010 |
Why?
|
Lumbar Vertebrae | 1 | 2010 | 1819 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2010 | 2679 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2012 | 2683 | 0.010 |
Why?
|
Brachytherapy | 1 | 2008 | 1242 | 0.010 |
Why?
|
Blood Pressure | 2 | 2011 | 8405 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2003 | 632 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1354 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4124 | 0.010 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1485 | 0.010 |
Why?
|
Binding Sites | 1 | 2009 | 6031 | 0.010 |
Why?
|
Disease Management | 1 | 2010 | 2457 | 0.010 |
Why?
|
Incidental Findings | 1 | 2004 | 685 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 2005 | 1204 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6840 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2499 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25765 | 0.010 |
Why?
|
Equipment Design | 1 | 2007 | 3513 | 0.010 |
Why?
|
Echocardiography | 1 | 2011 | 4910 | 0.010 |
Why?
|
Sex Distribution | 1 | 2003 | 2258 | 0.010 |
Why?
|
Bone Density | 1 | 2010 | 3510 | 0.010 |
Why?
|
Fibrinolytic Agents | 1 | 2007 | 2135 | 0.010 |
Why?
|
Medical Records | 1 | 2002 | 1392 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35465 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2003 | 2342 | 0.010 |
Why?
|
Lung Diseases | 1 | 2007 | 1903 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2006 | 1384 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2007 | 2074 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41409 | 0.010 |
Why?
|
Genetic Testing | 1 | 2009 | 3478 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1993 | 9107 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2006 | 2210 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4219 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3837 | 0.010 |
Why?
|
Thrombolytic Therapy | 1 | 2003 | 2072 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2008 | 3911 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2007 | 20143 | 0.010 |
Why?
|
Medicare | 1 | 2010 | 6569 | 0.010 |
Why?
|
Stem Cell Factor | 1 | 1993 | 198 | 0.010 |
Why?
|
Receptors, Interleukin-1 | 1 | 1993 | 261 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9128 | 0.010 |
Why?
|
Phenotype | 1 | 2009 | 16269 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2009 | 21698 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 1993 | 870 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 1993 | 1762 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2005 | 14543 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 1999 | 1867 | 0.010 |
Why?
|
Cholesterol | 1 | 1999 | 2881 | 0.010 |
Why?
|
Hypertension | 1 | 2008 | 8365 | 0.000 |
Why?
|
Disease Progression | 1 | 2004 | 13319 | 0.000 |
Why?
|
Lipopolysaccharides | 1 | 1993 | 2196 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1993 | 6517 | 0.000 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1993 | 4343 | 0.000 |
Why?
|
Neoplasms | 1 | 2009 | 21716 | 0.000 |
Why?
|
Mice | 1 | 1993 | 80264 | 0.000 |
Why?
|
Animals | 1 | 1993 | 166578 | 0.000 |
Why?
|